Reflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Reflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024 report and make more profitable business decisions.
Gastroesophageal reflux disease (GERD) refers to a condition where the liquid content of the stomach refluxes into the esophagus. It is a chronic condition. The symptoms of GERD are nausea, heartburn, and vomiting. The predisposing factors include eating large meals, which can cause the lower esophageal sphincter (LES) to open inappropriately, as well as obesity, pregnancy, greasy food, and certain drugs.
The Reflux Esophagitis (Gastroesophageal Reflux Disease) drugs in development market research report provide comprehensive information on the therapeutics under development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Reflux Esophagitis (Gastroesophageal Reflux Disease) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 42 molecules, with 42 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Reflux Esophagitis (Gastroesophageal Reflux Disease) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Reflux Esophagitis (Gastroesophageal Reflux Disease) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addpharma IncAhn-Gook Pharmaceutical Co Ltd
CalyGene Biotechnology Inc
Changchun Haiyue Pharmaceutical Co Ltd
Chong Kun Dang Pharmaceutical Corp.
Cinclus Pharma Holding AB
Daehan New Pharm Co Ltd
Daewoong Co Ltd
Eisai Co Ltd
EsoCap AG
Genuone Science Co Ltd
Hana Pharm Co Ltd
Harway Pharma Co Ltd
HK inno.N Corp
Huons Co Ltd
Ildong Pharmaceutical Co Ltd
ISOThrive Inc
Jiangsu Carephar Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Sinorda Biomedicine Co Ltd
JW Pharmaceutical Corp
Korea Pharma Co Ltd
Korea United Pharm Inc
Onconic Therapeutics Co Ltd
Phathom Pharmaceuticals Inc
RaQualia Pharma Inc
Sebela Pharmaceuticals Inc
Shanghai Haini Pharmaceutical Co Ltd
Sihuan Pharmaceutical Holdings Group Ltd
Trio Medicines Ltd
Xiamen Encheng Pharmaceutical Co Ltd
Yuhan Corp
Yungjin Pharm Co Ltd
Zein Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions